FASEB J.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by KEANEY, J. F.
Right arrow Articles by FREEDMAN, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by KEANEY, J. F., JR.
Right arrow Articles by FREEDMAN, J. E.
(The FASEB Journal. 1999;13:965-975.)
© 1999 FASEB

Vitamin E and vascular homeostasis: implications for atherosclerosis

JOHN F. KEANEY, JR.*1, DANIEL I. SIMON{dagger} and JANE E. FREEDMAN{ddagger}

* Evans Memorial Department of Medicine and Whitaker Cardiovascular Institute, Boston University School of Medicine, Boston, Massachusetts, 02118, USA;
{dagger} Cardiovascular Division, Brigham and Women's Hospital, Boston, Massachusetts 02114, USA; and
{ddagger} Departments of Medicine and Pharmacology, Georgetown University, Washington, D.C. 20007, USA

1Correspondence: Whitaker Cardiovascular Institute, Boston University School of Medicine, 715 Albany St., W507, Boston, MA 02118, USA. E-mail: jkeaney{at}bu edu

Considerable epidemiologic data suggest that dietary consumption of vitamin E reduces the incidence of cardiovascular disease. The precise mechanisms are not clear, but emerging data indicate that vitamin E has numerous activities that may, in part, explain its effect on vascular disease. In particular, vitamin E enhances the bioactivity of nitric oxide, inhibits smooth muscle proliferation, and limits platelet aggregation. One common mechanism to account for these effects of vitamin E is the inhibition of protein kinase C stimulation. In the setting of atherosclerosis, inhibition of protein kinase C by vitamin E would be expected to maintain normal vascular homeostasis and thus reduce the clinical incidence of cardiovascular disease.—Keaney, J. F., Jr., Simon, D. I., Freedman, J. E. Vitamin E and vascular homeostasis: implications for atherosclerosis.


Key Words: LDL • vascular homeostasis • {alpha}-tocopherol • nitric oxide




This article has been cited by other articles:


Home page
CLIN APPL THROMB HEMOSTHome page
R. Setiabudy, P. A. Wahidiyat, and L. Setiawan
Platelet Aggregation and Activation in Thalassemia Major Patients in Indonesia
Clinical and Applied Thrombosis/Hemostasis, July 1, 2008; 14(3): 346 - 351.
[Abstract] [PDF]


Home page
J. Lipid Res.Home page
T. J. Sontag and R. S. Parker
Influence of major structural features of tocopherols and tocotrienols on their {omega}-oxidation by tocopherol-{omega}-hydroxylase
J. Lipid Res., May 1, 2007; 48(5): 1090 - 1098.
[Abstract] [Full Text] [PDF]


Home page
J AndrolHome page
S. Wang, G. Wang, B. E. Barton, T. F. Murphy, and H. F. S. Huang
Beneficial Effects of Vitamin E in Sperm Functions in the Rat After Spinal Cord Injury
J Androl, March 1, 2007; 28(2): 334 - 341.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
M. G Traber
Heart disease and single-vitamin supplementation
Am. J. Clinical Nutrition, January 1, 2007; 85(1): 293S - 299S.
[Abstract] [Full Text] [PDF]


Home page
GENES CELLSHome page
R. Fukunaga-Takenaka, Y. Shirai, K. Yagi, N. Adachi, N. Sakai, E. Merino, I. Merida, and N. Saito
Importance of chroman ring and tyrosine phosphorylation in the subtype-specific translocation and activation of diacylglycerol kinase {alpha} by D-{alpha}-tocopherol
Genes Cells, April 1, 2005; 10(4): 311 - 319.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
C. C. McCormick and R. S. Parker
The Cytotoxicity of Vitamin E Is Both Vitamer- and Cell-Specific and Involves a Selectable Trait
J. Nutr., December 1, 2004; 134(12): 3335 - 3342.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
F. Krotz, H.-Y. Sohn, and U. Pohl
Reactive Oxygen Species: Players in the Platelet Game
Arterioscler. Thromb. Vasc. Biol., November 1, 2004; 24(11): 1988 - 1996.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
R. Stocker and J. F. Keaney Jr.
Role of Oxidative Modifications in Atherosclerosis
Physiol Rev, October 1, 2004; 84(4): 1381 - 1478.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Saito, Y. Yoshida, T. Akazawa, K. Takahashi, and E. Niki
Cell Death Caused by Selenium Deficiency and Protective Effect of Antioxidants
J. Biol. Chem., October 10, 2003; 278(41): 39428 - 39434.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
T. Kuroki, K. Isshiki, and G. L. King
Oxidative Stress: The Lead or Supporting Actor in the Pathogenesis of Diabetic Complications
J. Am. Soc. Nephrol., August 1, 2003; 14(90003): S216 - 220.
[Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
S. Devaraj and M. G Traber
{gamma}-Tocopherol, the new vitamin E?
Am. J. Clinical Nutrition, March 1, 2003; 77(3): 530 - 531.
[Full Text] [PDF]


Home page
CirculationHome page
R. M. Salonen, K. Nyyssonen, J. Kaikkonen, E. Porkkala-Sarataho, S. Voutilainen, T. H. Rissanen, T.-P. Tuomainen, V.-P. Valkonen, U. Ristonmaa, H.-M. Lakka, et al.
Six-Year Effect of Combined Vitamin C and E Supplementation on Atherosclerotic Progression: The Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) Study
Circulation, February 25, 2003; 107(7): 947 - 953.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
S. Devaraj, A. V. C. Chan Jr., and I. Jialal
{alpha}-Tocopherol Supplementation Decreases Plasminogen Activator Inhibitor-1 and P-Selectin Levels in Type 2 Diabetic Patients
Diabetes Care, March 1, 2002; 25(3): 524 - 529.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Coll. Nutr.Home page
C. S. Johnston and S. K. Cox
Plasma-Saturating Intakes of Vitamin C Confer Maximal Antioxidant Protection to Plasma
J. Am. Coll. Nutr., December 1, 2001; 20(6): 623 - 627.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
R. RICCIARELLI, J.-M. ZINGG, and A. AZZI
Vitamin E: protective role of a Janus molecule
FASEB J, November 1, 2001; 15(13): 2314 - 2325.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
K. Hayes, A. Pronczuk, and D. Perlman
Vitamin E in fortified cow milk uniquely enriches human plasma lipoproteins
Am. J. Clinical Nutrition, August 1, 2001; 74(2): 211 - 218.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
J. Bauersachs, I. Fleming, D. Fraccarollo, R. Busse, and G. Ertl
Prevention of endothelial dysfunction in heart failure by vitamin E: Attenuation of vascular superoxide anion formation and increase in soluble guanylyl cyclase expression
Cardiovasc Res, August 1, 2001; 51(2): 344 - 350.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
M. G. Traber
Does Vitamin E Decrease Heart Attack Risk? Summary and Implications with Respect to Dietary Recommendations
J. Nutr., February 1, 2001; 131(2): 395S - 397.
[Abstract] [Full Text]


Home page
Exp. Biol. Med.Home page
N. Kaul, S. Devaraj, and I. Jialal
{{alpha}}-Tocopherol and Atherosclerosis
Experimental Biology and Medicine, January 1, 2001; 226(1): 5 - 12.
[Abstract] [Full Text]


Home page
J. Lipid Res.Home page
W. Witt, I. Kolleck, H. Fechner, P. Sinha, and B. Rüstow
Regulation by vitamin E of the scavenger receptor BI in rat liver and HepG2 cells
J. Lipid Res., December 1, 2000; 41(12): 2009 - 2016.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
Y. Terasawa, Z. Ladha, S. W. Leonard, J. D. Morrow, D. Newland, D. Sanan, L. Packer, M. G. Traber, and R. V. Farese Jr.
Increased atherosclerosis in hyperlipidemic mice deficient in alpha -tocopherol transfer protein and vitamin E
PNAS, November 22, 2000; (2000) 240462697.
[Abstract] [Full Text]


Home page
CirculationHome page
F. de Nigris, T. Youssef, S. Ciafre, F. Franconi, V. Anania, G. Condorelli, W. Palinski, and C. Napoli
Evidence for Oxidative Activation of c-Myc-Dependent Nuclear Signaling in Human Coronary Smooth Muscle Cells and in Early Lesions of Watanabe Heritable Hyperlipidemic Rabbits : Protective Effects of Vitamin E
Circulation, October 24, 2000; 102(17): 2111 - 2117.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
R. Asmis and J. Jelk
Vitamin E Supplementation of Human Macrophages Prevents Neither Foam Cell Formation Nor Increased Susceptibility of Foam Cells to Lysis by Oxidized LDL
Arterioscler. Thromb. Vasc. Biol., September 1, 2000; 20(9): 2078 - 2086.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
N. S. Dhalla, A. B. Elmoselhi, T. Hata, and N. Makino
Status of myocardial antioxidants in ischemia-reperfusion injury
Cardiovasc Res, August 18, 2000; 47(3): 446 - 456.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
B. FREI
Molecular and biological mechanisms of antioxidant action
FASEB J, June 1, 1999; 13(9): 963 - 964.
[Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
Y. Terasawa, Z. Ladha, S. W. Leonard, J. D. Morrow, D. Newland, D. Sanan, L. Packer, M. G. Traber, and R. V. Farese Jr.
Increased atherosclerosis in hyperlipidemic mice deficient in alpha -tocopherol transfer protein and vitamin E
PNAS, December 5, 2000; 97(25): 13830 - 13834.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by The Federation of American Societies for Experimental Biology.